The impact of chronic inflammation on bone turnover in hemodialysis patients

Renal Failure

Volumn 30, Issue 4, 2008, Pages 431-437

  Eleftheriadis, Theodoros ^a   Kartsios, Charalambos ^b   Antoniadi, Georgia ^a   Kazila, Polizo ^b   Dimitriadou, Magdalini ^b   Sotiriadou, Eleni ^b   Koltsida, Maria ^b   Golfinopoulos, Spiridon ^a   Liakopoulos, Vassilios ^a   Christopoulou Apostolaki, Maria ^b  

^a General District Hospital of Serres   (Greece)

^b THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

Bone turnover; Hemodialysis; Inflammation; Renal osteodystrophy

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN TYPE 1; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; OSTEOCALCIN; PARATHYROID HORMONE; RHO FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANURIA; ARTICLE; BLOOD SAMPLING; BONE DEVELOPMENT; BONE METABOLISM; BONE MINERALIZATION; BONE TURNOVER; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IMMUNE SYSTEM; IMMUNOASSAY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; OSTEOCLAST; OSTEOLYSIS; OSTEOMALACIA; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RENAL OSTEODYSTROPHY; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

AGED; BONE REMODELING; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HISTORY, ANCIENT; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; LONG-TERM CARE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROGNOSIS; RENAL DIALYSIS; RENAL OSTEODYSTROPHY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 45749129873     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220801964251     Document Type: Article

References (32)

1. Malluche HH, Langub MC, Monier-Faugere MC. The role of bone biopsy in clinical practice and research. Kidney Int Suppl. 1999;73:S20-S25.
2. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:1-201.
3. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis. 1995;26(4):622-631.
4. Saidenberg-Kermanac'h N, Cohen-Solal M, Bessis N, De Vernejoul MC, Boissier MC. Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine. 2004;71(1):9-13.
5. Walsh NC, Crotti TN, Goldring SR, Gravallese EM. Rheumatic diseases: The effects of inflammation on bone. Immunol Rev. 2005;208:228-251.
6. Klein B, Wijdenes J, Zhang XG, Jourdan M, Boiron JM, Brochier J, Liautard J, Merlin M, Clement C, Morel-Fournier B, Lu ZY, Mannoni P, Sany J, Bataille R. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood. 1991;78(5):1198-1204.
7. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science. 1992;257(5066):88-91.
8. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, Kim GS. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: Evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005;16(10):1263-1271.
9. Schindler R, Linnenweber S, Schulze M, Oppermann M, Dinarello CA, Shaldon S, Koch KM. Gene expression of interleukin-1 beta during hemodialysis. Kidney Int. 1993;43(3):712-721.
10. Girndt M, Kohler H, Schiedhelm-Weick E, Schlaak JF, Meyer zum Buschenfelde KH, Fleischer B. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int. 1995;47(2):559-565.
11. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54(2):627-636.
12. Takahashi M, Kushida K, Nagano A, Inoue T. Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay. Clin Chim Acta. 2000;294(1-2):67-76.
13. Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, Masaki H, Moriguchi A, Nishizawa Y. Clinical evaluation of the Elecsys beta-CrossLaps serum assay: A new assay for degradation products of type I collagen C-tlopeptides. Clin Chem. 2001;47(8):1410-1414.
14. Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant. 1998;13(9):2294-2302.
15. Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int. 1999;56(3):1084-1093.
16. Manolagas SC. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21(2):115-137.
17. Kushner I. Regulation of the acute phase response by cytokines. Perspect Biol Med. 1993;36(4):611-622.
18. Abrahamsen B, Bonnevie-Nielsen V, Ebbesen EN, Gram J, Beck-Nielsen H. Cytokines and bone loss in a five-year longitudinal study - hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study. J Bone Miner Res. 2000;15(8):1545-1554.
19. Salamone LM, Whiteside T, Friberg D, Epstein RS, Kuller LH, Cauley JA. Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women. Calcif Tissue Int. 1998;63(6):466-470.
20. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990;145(10):3297- 3303.
21. Abdallah BM, Stilgren LS, Nissen N, Kassem M, Jørgensen HR, Abrahamsen B. Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures. Calcif Tissue Int. 2005;76(2):90-97.
22. Huang W, Drissi MH, O'Keefe RJ, Schwarz EM. A rapid multiparameter approach to study factors that regulate osteoclastogenesis: Demonstration of the combinatorial dominant effects of TNF-alpha and TGF-ss in RANKL-mediated osteoclastogenesis. Calcif Tissue Int. 2003;73(6):584-593.
23. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 1994;13(5):1189-1196.
24. Balto K, Sasaki H, Stashenko P. Interleukin-6 deficiency increases inflammatory bone destruction. Infect Immun. 2001;69(2):744-750.
25. Montalbán C, García-Unzueta MT, De Francisco AL, Amado JA. Serum interleukin-6 in renal osteodystrophy: relationship with serum PTH and bone remodeling markers. Horm Metab Res. 1999;31(1):14-17.
26. Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption - a clinical research center study. J Clin Endocrinol Metab. 1996;81(10):3450-3454.
27. Guo CY, Holland PA, Jackson BF, Hannon RA, Rogers A, Harrison BJ, Eastell R. Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism. Eur J Endocrinol. 2000;142(5):451-459.
28. Stilgren L. Molecular mechanisms of parathyroid hormone action on the skeleton in primary hyperparathyroidism. Dan Med Bull. 2004;51:310.
29. O'Brien CA, Jilka RL, Fu Q, Stewart S, Weinstein RS, Manolagas SC. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab. 2005;289(5):E784-E793.
30. Salusky IB, Goodman WG. Adynamic renal osteodystrophy: Is there a problem? J Am Soc Nephrol. 2001;12(9): 1978-1985.
31. Grimble RF. Inflammatory response in the elderly. Curr Opin Clin Nutr Metab Care. 2003;6(1):21-29.
32. Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, Kalofoutis A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann NY Acad Sci. 2006;1084:89-117.